Modification of 21 CFR Pt. 101.93 to Include Structure/Function ClaIms with Disclaimers that Eliminate Perceived Disease Connotations.
🏛 Food and Drug Administration (FDA)FDA-2004-P-0153
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.